** Shares of medical technology co ZimVie Inc ZIMV.O up
about 23% at $9.5 in extended trading
** Says recently initiated additional restructuring
activities and expects about 5% reduction in global workforce
** Raises FY2023 net sales outlook to $835 mln-$860 mln from
prior guidance of $825 mln-$850 mln
** Raises FY2023 adj EPS outlook to $0.40-$0.60 from prior
guidance of $0.30-$0.50
** Co estimates restructuring activities to generate $17-20
mln in annualized net savings by 2024
** Reports third party net sales of $225.1 mln, adj EPS of
25 cents in Q1
** ZIMV down about 17.5% YTD
(Reporting by Vaibhav Sadhamta)
((Vaibhav.Sadhamta@thomsonreuters.com;))